Literature DB >> 25362

Benzodiazepine binding in human brain: characterization using [3H]flunitrazepam.

R C Speth, G J Wastek, P C Johnson, H I Yamamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 25362     DOI： 10.1016/0024-3205(78)90610-0

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  26 in total

1.  Benzodiazepine receptors in the brain as affected by different experimental stresses: the changes are small and not undirectional.

Authors:  C Braestrup; M Nielsen; E B Nielsen; M Lyon
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

Review 2.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

3.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.

Authors:  A Schotte; P F Janssen; W Gommeren; W H Luyten; P Van Gompel; A S Lesage; K De Loore; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

4.  Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study.

Authors:  G J Blatt; C M Fitzgerald; J T Guptill; A B Booker; T L Kemper; M L Bauman
Journal:  J Autism Dev Disord       Date:  2001-12

5.  Effects of diazepam on the latency of saccades for luminance and binocular disparity defined stimuli.

Authors:  Cunguo Wang; Jianliang Tong; Fuchuan Sun
Journal:  Exp Brain Res       Date:  2005-04-08       Impact factor: 1.972

6.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

7.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 8.  From binding studies to the molecular biology of GABA receptors.

Authors:  R J Knapp; E Malatynska; H I Yamamura
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

9.  Effects of diazepam on closed- and open-loop optokinetic nystagmus (OKN) in humans.

Authors:  Jing Tian; Min Wei; Pei-Ji Liang; Fuchuan Sun
Journal:  Exp Brain Res       Date:  2003-09-02       Impact factor: 1.972

Review 10.  Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.